Scientists have identified a gene that can help doctors predict which patients are likely to develop severe ulcerative colitis. The breakthrough, made by Danish researchers, means that for the first ...

Bacteria from the mouth could hold clues to understanding – and potentially treating – severe ulcerative colitis, a painful bowel disease. Severe ulcerative colitis - a form of inflammatory bowel ...

Ulcerative colitis is a chronic condition characterized by inflammation and ulcers in the colon. Research is ongoing to expand treatment options. A study published in the New England Journal of ...

In a recent study published in the JAMA, a group of researchers identified biomarkers of severe ulcerative colitis through a Danish genome-wide association study (GWAS). Ulcerative colitis is a ...

VIENNA — Individuals with ulcerative colitis (UC) who carry the HLA-DRB1*01:03 allele are at increased risk of having a more severe disease course requiring major surgery, hospitalization, and ...

A new study reveals how gut bacteria may initiate ulcerative colitis by weakening immune defenses before inflammation occurs.

Share on Pinterest Officials say Zeposia could reduce symptoms of ulcerative colitis in adults. Pixels Effect/Getty Images Federal regulators have approved the new drug Zeposia for treating moderate ...

Researchers examined treatment and prognosis for severe-onset ulcerative colitis in children. Children with severe-onset ulcerative colitis may require treatment with biologic agents. Severe-onset ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Please provide your email address to receive an email when new articles are posted on . Zeposia (Ozanimod, Bristol Myers Squibb), the first sphingosine 1-phosphate (S1P) receptor modulator approved ...

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients with ...